Advertisement

Advertisement

Announcements

Atrium Health and Wake Forest University School of Medicine Cancer Program Appoint New Director

The ASCO Post Staff  /  January 25, 2023

Atrium Health recently announced that Ruben A. Mesa, MD, FACP, has been named President and Executive Director of its cancer service line—which includes both Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center—and Vice Dean for Cancer Programs at W...

Inaugural Recipients of the Lubin Family Foundation Scholar Award Named

The ASCO Post Staff  /  January 25, 2023

The four inaugural recipients of the Lubin Family Foundation Scholar Award have been announced by Dana-Farber Cancer Institute and the Richard K. Lubin Family Foundation. Lubin Scholars are among the most promising physician-scientists pursuing cancer-relevant basic or translational laboratory-based...

Andrea Schietinger, PhD, to Present 2023 AACR–Irving Weinstein Foundation Distinguished Lecture

The ASCO Post Staff  /  January 25, 2023

The American Association for Cancer Research (AACR) will award the 19th AACR–Irving Weinstein Foundation Distinguished Lectureship to Andrea Schietinger, PhD, during the 2023 AACR Annual Meeting, held April 14–19, in Orlando, Florida. Dr. Schietinger, an associate member of the Immunology Program at...

KU Medical Center Researchers Receive R01 Grant From NCI to Improve Access to Targeted Cancer Treatments for Rural Patients

The ASCO Post Staff  /  January 25, 2023

Precision medicine has revolutionized cancer treatment—but only for patients who have access to treatments. Nearly 2 million people in the United States are diagnosed each year with cancer, but access to targeted treatments varies widely, and only about half of the eligible people receive them, said...

Northwell Receives Gift From Trustee Roy J. Zuckerberg to Create First Cancer Hospital and Cancer Campus on Long Island

The ASCO Post Staff  /  January 25, 2023

Northwell Health recently announced a gift from longtime trustee Roy J. Zuckerberg to create the R.J. ­Zuckerberg Cancer Hospital at Long Island Jewish (LIJ) Medical Center—Long Island’s first cancer hospital—and to establish the R.J. Zuckerberg Cancer Center, Northwell’s largest ambulatory cancer c...

NRG Oncology Announces Leadership of New DEI Committee and New Vice Chair for Ancillary Projects Committee

The ASCO Post Staff  /  January 25, 2023

NRG Oncology, a National Cancer Institute (NCI) National Clinical Trials Network (NTCN) group focused on improving outcomes for adults with cancer through international clinical research, recently announced the appointed leadership of the organization’s new Diversity, Equity, and Inclusion (DEI) Com...

Maureen Murphy, PhD, Named Deputy Director of the Wistar Institute’s Ellen and Ronald Caplan Cancer Center

The ASCO Post Staff  /  January 25, 2023

The Ellen and Ronald Caplan Cancer Center at The Wistar Institute, Philadelphia, has announced the appointment of the Ira Brind Endowed Professor, Maureen Murphy, PhD, as Deputy Director. Dr. Murphy will guide the growth of the Cancer Center through expanding research initiatives and collaboration, ...

Northwell Cancer Institute Welcomes New Chief of Hematologic Malignancies

The ASCO Post Staff  /  January 25, 2023

Northwell Health recently appointed Douglas Gladstone, MD, a leader in hematology and medical oncology, as Chief of Hematologic Malignancies at the Northwell Health Cancer Institute. Prior to joining Northwell, Dr. Gladstone served for 14 years as Clinical Director of the outpatient bone marrow tra...

Yale Cancer Center Presents 2022 Research Awards

The ASCO Post Staff  /  January 25, 2023

Yale Cancer Center’s Annual Conclave, held on January 5, recognized the scientific and clinical accomplishments of the Center’s faculty and staff in 2022. Eric Winer, MD, hosted the event and presented research awards in four categories: The Yale Cancer Center Population Science Research Prizes wer...

Cleveland Clinic Appoints Alex A. Adjei, MD, PhD, as Chair of Taussig Cancer Institute

The ASCO Post Staff  /  July 10, 2022

Alex A. Adjei, MD, PhD, is the new Chair of Cleveland Clinic Taussig Cancer Institute. Previously, he served as Consultant in Oncology, Professor of Oncology and Professor of Pharmacology at Mayo Clinic and Mayo Clinic College of Medicine and Science in Rochester, Minnesota. Dr. Adjei also oversaw ...

Barbara Burtness, MD, Named Chief Translational Research Officer for Yale Cancer Center and Smilow Cancer Hospital

The ASCO Post Staff  /  December 25, 2022

Barbara Burtness, MD, Professor of Medicine (Medical Oncology), has been named Chief Translational Research Officer for Yale Cancer Center and Smilow Cancer Hospital and Associate Cancer Center Director for Translational Research for Yale Cancer Center. Dr. Burtness’ experience, leadership, and ment...

Eyal Gottlieb, PhD, to Join MD Anderson as Vice President for Research

The ASCO Post Staff  /  December 25, 2022

The University of Texas MD Anderson Cancer Center recently announced that Eyal Gottlieb, PhD, has been named the institution’s Vice President for Research. In this role, Dr. Gottlieb will oversee laboratory science departments leading innovative discovery and translational research across a variety ...

2022 San Antonio Breast Cancer Symposium Award Recipients Announced

The ASCO Post Staff  /  December 25, 2022

The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an SABCS cosponsor, honored two researchers for their significant contributions to breast cancer research at the 2022 SABCS. 2022 AACR Distinguished Lectureship in Breast Cancer Research Charle...

Immunotherapy

2021 JADPRO Article of the Year Award Spotlights Management of Adverse Events in Immunotherapy

The ASCO Post Staff  /  December 25, 2022

A team of advanced practice providers in the Department of Hematology/Oncology at Fox Chase Cancer Center have received the 2021 Article of the Year Award from the Journal of the Advanced Practitioner in Oncology (JADPRO). This award is given to one article each year that demonstrates an exceptional...

MD Anderson and WHO Establish a New International Collaboration to Reduce the Global Burden of Women’s Cancers

The ASCO Post Staff  /  December 25, 2022

The University of Texas MD Anderson Cancer Center and the World Health Organization (WHO) recently announced a formal agreement to establish a new international collaboration concentrated on reducing the global burden of women’s cancers. The agreement builds on years of collaboration between the two...

Cedars-Sinai Cancer Leaders Assume New Roles

The ASCO Post Staff  /  December 25, 2022

Lali Medina-Kauwe, PhD, former Co-Leader of the Cancer Biology Program in Cedars-Sinai Cancer, assumed a new role as Associate Director for Basic Research. The Cancer Biology Program will now be led by Dolores Di Vizio, MD, PhD, Professor of Biomedical Sciences, Pathology and Laboratory Medicine in ...

Fox Chase Receives $6 Million Grant as Founding Member of New NCI Prevention Initiative

The ASCO Post Staff  /  December 25, 2022

Fox Chase Cancer Center was recently awarded a grant for $6 million over the course of 5 years to develop a new Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT). The new National Cancer Institute (NCI) program was created to establish a pipeline for the discovery of new cance...

Sidney Kimmel Cancer Center Establishes Geriatric Oncology Center of Excellence at Jefferson Health

The ASCO Post Staff  /  December 25, 2022

Jefferson Health’s Sidney Kimmel Cancer Center (SKCC) recently launched the Geriatric Oncology Center of Excellence to address the needs of a growing patient population through innovative research and care delivery methods via a multidisciplinary approach. The center identifies and removes barriers ...

Indiana University Names Music Therapy Researcher Sheri Robb, PhD, as New Walther Professor of Supportive Oncology

The ASCO Post Staff  /  December 25, 2022

Indiana University (IU) School of Medicine has named Sheri Robb, PhD, a Walther Professor of Supportive Oncology. This is one of five endowed positions to develop a supportive oncology program that encompasses research and patient care. Dr. Robb is a nationally renowned music therapy researcher, P...

National Academy of Medicine Elects 100 New Members

The ASCO Post Staff  /  December 10, 2022

The National Academy of Medicine recently announced the election of 90 regular members and 10 international members during its annual meeting. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstan...

ASTRO Celebrates Contributions to Radiation Oncology With 2022 Gold Medals and Other Awards

The ASCO Post Staff  /  December 10, 2022

The American Society for Radiation Oncology (ASTRO) recognized the recipients of its 2022 Gold Medal awards and other high-profile honors during an awards ceremony at the 2022 ASTRO Annual Meeting in San Antonio. ASTRO Gold Medal Wendell R. Lutz, PhD, and Tim R. Williams, MD, FASTRO, were awarded ...

Colorectal Cancer

Phase III FRESCO-2 Trial of Fruquintinib Meets Primary Endpoint in Metastatic Colorectal Cancer

The ASCO Post Staff  /  November 10, 2022

HUTCHMED (China) Limited recently announced that the global phase III FRESCO-2 trial evaluating the investigational use of the anti–vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor fruquintinib met its primary endpoint of overall survival in patients with advanced, refractory meta...

CNS Cancers

Report on Brain Cancer: Crisis in the Childhood and Adolescent Cancer Community

The ASCO Post Staff  /  November 25, 2022

A RECENT REPORT published in Neuro-Oncology1 exposes an alarming reality for children, adolescents, and families facing pediatric brain cancer across the country. The Pediatric Brain Tumor Foundation (PBTF) funded this groundbreaking report by the Central Brain Tumor Registry of the United States (C...

Pharmacology Researcher James Turkson, PhD, to Become Director for Diversity, Inclusion, and Strategy at Cedars-Sinai

The ASCO Post Staff  /  November 25, 2022

JAMES TURKSON, PhD, Professor in the Division of Medical Oncology in the Department of Medicine at Cedars-Sinai, is uniquely positioned for a new role developed at Cedars-Sinai Cancer: Director for Diversity, Inclusion, and Strategy. “I have great confidence that Dr. Turkson will provide superb lead...

Annual Report to the Nation: Cancer Deaths Continue Downward Trend

The ASCO Post Staff  /  November 25, 2022

OVERALL CANCER death rates continued to decline among men, women, children, and adolescents/young adults in every major racial and ethnic group in the United States from 2015 to 2019, according to the latest Annual Report to the Nation on the Status of Cancer.1 From 2014 to 2018, the overall cancer ...

New Leadership Elected to the American Society of Hematology

The ASCO Post Staff  /  November 25, 2022

The American Society of Hematology (ASH) recently announced the election of four new members to its Executive Committee for terms beginning after the 2022 ASH Annual Meeting & Exposition in December in New Orleans. Belinda R. Avalos, MD, will serve a 1-year term as Vice President, followe...

Erica Huelsmann, MD, Wins a Conquer Cancer Annual Meeting Merit Award

The ASCO Post Staff  /  November 10, 2022

Erica Huelsmann, MD, a gynecologic oncology fellow at Fox Chase Cancer Center, Philadelphia, has been awarded a 2022 Conquer Cancer Merit Award by Conquer Cancer, the ASCO Foundation. The award, given at the 2022 ASCO Annual Meeting, supports researchers with projects that span many areas of cance...

Yuan Yuan, MD, PhD, Joins Cedars-Sinai Cancer Medical Center as Director of Breast Oncology

The ASCO Post Staff  /  November 10, 2022

Cedars-Sinai Cancer Medical Center recently announced the appointment of Yuan Yuan, MD, PhD, a breast medical oncologist and physician scientist who specializes in triple-negative breast cancer and breast cancer immunotherapy, as Director of Breast Oncology. Finding Cutting-Edge Therapies “[Trip...

SWOG Names Don S. Dizon, MD, Vice Chair for Diversity, Equity, Inclusion, and Professional Integrity

The ASCO Post Staff  /  November 10, 2022

After nearly a year-long search, the Southwest Oncology Group (SWOG) has announced its new Vice Chair for Diversity, Equity, Inclusion (DEI), and Professional Integrity: Don S. Dizon, MD, who is currently Chair of the organization’s Digital Engagement Committee. Dr. Dizon is Director of the Pelvic M...

UChicago Medicine Names New Associate Director of Cancer Prevention and Population Sciences

The ASCO Post Staff  /  November 10, 2022

Jasmin A. Tiro, PhD, MPH, has joined the University of Chicago Medicine Comprehensive Cancer Center as the new Associate Director of Cancer Prevention and Population Sciences. Dr. Tiro was formerly Professor of Population and Data Sciences at Harold C. Simmons Comprehensive Cancer Center at The Univ...

NCI Honors Augusto Ochoa, MD, for Contributions to Community-Based Cancer Clinical Trials

The ASCO Post Staff  /  November 10, 2022

The National Cancer Institute (NCI) chose Augusto Ochoa, MD, of Louisiana State University (LSU) Health, as the 2022 recipient of the Harry Hynes Award for Outstanding Contributions to Clinical Trials and Community Research. The award was presented during the NCI Community Oncology Research Program ...

Pediatric Surgeon Henri R. Ford, MD, Chosen New President-Elect of American College of Surgeons

The ASCO Post Staff  /  November 10, 2022

Pediatric surgeon and surgeon-scientist Henri R. Ford, MD, MHA, FACS, FRCS, FAAP, has been chosen as President-Elect of the American College of Surgeons during the organization’s recent annual business meeting of members. The First Vice-President-Elect, Tyler G. Hughes, MD, FACS, and Second Vice-Pre...

YES Oklahoma Project Created to Improve Representation of Native Americans in Cancer Research

The ASCO Post Staff  /  October 25, 2022

The National Cancer Institute of the National Institutes of Health (NIH) has awarded the University of Oklahoma (OU) an expected $2 million over 5 years to develop a program to improve representation of Oklahoma Native American students in biomedical and cancer research. “American Indian professi...

Incarceration May Be Associated With Higher Cancer Mortality, Yale Study Shows

The ASCO Post Staff  /  October 25, 2022

New research from Yale Cancer Center reveals a higher risk of cancer mortality in incarcerated adults, as well as among those diagnosed with cancer in the first year after release from prison. The findings were published in the journal PLoS One.1 “Cancer is the leading cause of death among people i...

Vanderbilt University Medical Center Selects New Director of the Division of Infectious Diseases

The ASCO Post Staff  /  October 10, 2022

Kelly Dooley, MD, PhD, MPH, has been appointed Addison B. Scoville Jr. Professor of Medicine and Director of the Division of Infectious Diseases in the Department of Medicine at Vanderbilt University Medical Center (VUMC). Dr. Dooley comes to Vanderbilt from The Johns Hopkins School of Medicine in B...

Stephen A. Strickland, Jr, MD, MSCI, Joins the Sarah Cannon Transplant & Cellular Therapy Network

The ASCO Post Staff  /  October 10, 2022

Sarah Cannon, the Cancer Institute of HCA Healthcare, announced recently that Stephen A. Strickland, Jr, MD, MSCI, has been named the Director of Leukemia Research for the Transplant & Cellular Therapy Network. In this role, Dr. Strickland provides scientific leadership and oversees Sarah Cannon...

Massey Cancer Center and VCU Health Appoint Paula M. Fracasso, MD, PhD, FACP, to Leadership Roles

The ASCO Post Staff  /  October 10, 2022

Paula M. Fracasso, MD, PhD, FACP, has joined Virginia Commonwealth University (VCU) Massey Cancer Center and VCU Health as Deputy Director of the cancer center and Senior Vice President of the cancer service line at VCU Health. The cancer service line is a collaborative model designed to fulfill...

Scott M. Welford, PhD, Named Sylvester’s Tumor Biology Research Program Co-Leader

The ASCO Post Staff  /  October 10, 2022

Scott M. Welford, PhD, Professor and Biology Division Chief in Radiation Oncology at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, will lead the center’s Tumor Biology Research Program with Wael El-Rifai, MD, PhD, Associate Director of Basic Science at...

Shaji K. Kumar, MD, Named Editor-in-Chief of The Hematologist

The ASCO Post Staff  /  October 10, 2022

Shaji K. Kumar, MD, an expert in multiple myeloma and monoclonal gammopathies, has been appointed to the position of Editor-in-Chief of The Hematologist: ASH News and Reports, the official member news magazine of the American Society of Hematology (ASH). As the seventh Editor-in-Chief of the pub...

Reshma Jagsi, MD, DPhil, FASCO, Named New Chair of Emory Radiation Oncology

The ASCO Post Staff  /  October 10, 2022

Reshma Jagsi, MD, DPhil, FASCO, recently joined Emory School of Medicine as Chair of the Department of Radiation Oncology. Dr. Jagsi was formerly the Newman Family Professor, Deputy Chair, and Residency Program Director in the Department of Radiation Oncology and Director of the Center for Bioethi...

Cristina R. Ferrone, MD, Named Chair of Cedars-Sinai Department of Surgery

The ASCO Post Staff  /  October 10, 2022

Following an extensive national search, Cedars-Sinai Medical Center, Los Angeles, has appointed Cristina R. Ferrone, MD, as Chair of the Department of Surgery. Currently Professor of Surgery at Harvard Medical School and Director of the Office of Clinical Careers for Massachusetts General Hospit...

Loïc Le Marchand, MD, PhD, MPH, Awarded 2022 AACR Lectureship on Science of Cancer Health Disparities

The ASCO Post Staff  /  September 25, 2022

The American Association for Cancer Research (AACR) has announced Loïc Le Marchand, MD, PhD, MPH, as the recipient of the 2022 AACR Distinguished Lectureship on the Science of Cancer Health Disparities. Dr. Le Marchand presented his award lecture, “Translating Multiethnic Epidemiological Research In...

BRCA Gene Testing for Men: MSK Launches Cancer Screening Clinic

The ASCO Post Staff  /  September 10, 2022

Perhaps the best known of all cancer predisposition genes are inherited mutations in the genes BRCA1 and BRCA2. They were originally associated with an increased risk of breast and ovarian cancers. Later studies revealed that they also increased the risk of prostate and pancreatic cancers and, in so...

Association of Community Cancer Centers Announces 2022 Innovator Award Winner, Ochsner Cancer Institute

The ASCO Post Staff  /  September 10, 2022

The Association of Community Cancer Centers (ACCC) recently announced that Ochsner Cancer Institute in New Orleans is a recipient of a 2022 ACCC Innovator Award. The award recognizes Ochsner Cancer Institute’s Chemotherapy Care Companion program—a digital technology system that allows the cancer car...

Allison Institute Announces Creation of Scientific Advisory Board

The ASCO Post Staff  /  September 10, 2022

The James P. Allison Institute at The University of Texas MD Anderson Cancer Center, Houston, recently announced the establishment of its scientific advisory board to provide strategic guidance and evaluation of its research portfolio and programs. The 11-person advisory board will be co-chaired by ...

IASLC Names Co-Chairs of the 2023 World Conference on Lung Cancer

The ASCO Post Staff  /  September 10, 2022

Three thoracic oncologists were named co-chairs of the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer (WCLC), which will take place September 9–12 in Singapore. Co-chairs work with IASLC to plan the annual research meeting, select program track me...

Neurosurgeon Ashish Shah, MD, Returns to Sylvester to Head Clinical Trials and Translational Research on Brain Tumors

The ASCO Post Staff  /  September 10, 2022

Ashish Shah, MD, has assumed the newly created position of Director of Clinical Trials and Translational Research and principal investigator in the Section of Virology and Immunotherapy at Sylvester Comprehensive Cancer Center’s Brain Tumor Initiative (BTI) at the University of Miami Miller School...

Thomas J. Herzog, MD, to Serve as Board President-Elect of the GOG Foundation, Inc, for Gynecologic Malignancies

The ASCO Post Staff  /  September 10, 2022

The GOG Foundation, Inc (GOG-F), Board of Directors recently announced the election of Thomas J. Herzog, MD, as its next President, succeeding Larry J. Copeland, MD, who has served in this role since 2017. Under Dr. Copeland’s leadership, the GOG-F has experienced unprecedented growth in its clinica...

Sylvester Researchers Receive $9.5 Million Grant to Study Esophageal Cancer

The ASCO Post Staff  /  September 10, 2022

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have received a $9.5 million National Cancer Institute Program Project (P01) grant to investigate esophageal adenocarcinoma. “People with chronic gastroesophageal reflux disease can develop a p...

The Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine Appoints New Directors

The ASCO Post Staff  /  August 25, 2022

Jedd Wolchok, MD, PhD, FASCO, an internationally acclaimed medical oncologist whose innovations in immunotherapy have revolutionized melanoma treatment, has been chosen as the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. Dr. Wolchok played a pivotal role i...

Advertisement

Advertisement



Advertisement